Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae D Van Duin, JJ Lok, M Earley, E Cober, SS Richter, F Perez, RA Salata, ... Clinical Infectious Diseases 66 (2), 163-171, 2018 | 583 | 2018 |
Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment YM van der Linden, JJ Lok, E Steenland, H Martijn, H van Houwelingen, ... International Journal of Radiation Oncology* Biology* Physics 59 (2), 528-537, 2004 | 344 | 2004 |
Comparative analysis of risk factors for pathological fracture with femoral metastases: results based on a randomised trial of radiotherapy YM Van der Linden, PDS Dijkstra, HM Kroon, JJ Lok, EM Noordijk, ... The Journal of Bone & Joint Surgery British Volume 86 (4), 566-573, 2004 | 268 | 2004 |
Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis RJK Hettiarachchi, J Lok, MH Prins, HR Büller, P Prandoni Cancer 83 (1), 180-185, 1998 | 257 | 1998 |
No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT HJ Ribaudo, CA Benson, Y Zheng, SL Koletar, AC Collier, JJ Lok, ... Clinical Infectious Diseases 52 (7), 929-940, 2011 | 183 | 2011 |
Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection JJ Lok, RJ Bosch, CA Benson, AC Collier, GK Robbins, RW Shafer, ... Aids 24 (12), 1867-1876, 2010 | 161 | 2010 |
Simple radiographic parameter predicts fracturing in metastatic femoral bone lesions: results from a randomised trial YM van der Linden, HM Kroon, SPDS Dijkstra, JJ Lok, EM Noordijk, ... Radiotherapy and Oncology 69 (1), 21-31, 2003 | 136 | 2003 |
Exercise therapy after coronary artery bypass graft surgery: a randomized comparison of a high and low frequency exercise therapy program ID van der Peijl, TPMV Vlieland, MIM Versteegh, JJ Lok, M Munneke, ... The Annals of thoracic surgery 77 (5), 1535-1541, 2004 | 91 | 2004 |
Randomized trial evaluating clinical impact of RAPid identification and susceptibility testing for Gram-negative bacteremia: RAPIDS-GN R Banerjee, L Komarow, A Virk, N Rajapakse, AN Schuetz, B Dylla, ... Clinical Infectious Diseases 73 (1), e39-e46, 2021 | 88 | 2021 |
Statistical modeling of causal effects in continuous time JJ Lok The Annals of Statistics 36 (3), 1464-1507, 2008 | 73 | 2008 |
Estimating the causal effect of a time‐varying treatment on time‐to‐event using structural nested failure time models J Lok, R Gill, A Van Der Vaart, J Robins Statistica Neerlandica 58 (3), 271-295, 2004 | 61 | 2004 |
Variable selection for confounder control, flexible modeling and collaborative targeted minimum loss-based estimation in causal inference ME Schnitzer, JJ Lok, S Gruber The international journal of biostatistics 12 (1), 97-115, 2016 | 49 | 2016 |
Defining and estimating causal direct and indirect effects when setting the mediator to specific values is not feasible JJ Lok Statistics in medicine 35 (22), 4008-4020, 2016 | 41 | 2016 |
Sensitivity analysis for unmeasured confounding in coarse structural nested mean models S Yang, JJ Lok Statistica Sinica 28 (4), 1703, 2018 | 35 | 2018 |
Antibacterial Resistance Leadership Group. Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae D Van Duin, JJ Lok, M Earley, E Cober, SS Richter, F Perez, RA Salata, ... Clin Infect Dis 66 (2), 163-171, 2018 | 27 | 2018 |
Impact of time to start treatment following infection with application to initiating HAART in HIV‐positive patients JJ Lok, V DeGruttola Biometrics 68 (3), 745-754, 2012 | 27 | 2012 |
Statistical modelling of causal effects in time JJ Lok | 27 | 2001 |
ACTG A5001/ALLRT Protocol Team. No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG … HJ Ribaudo, CA Benson, Y Zheng, SL Koletar, AC Collier, JJ Lok, ... Clin Infect Dis 52 (7), 929-940, 2011 | 22 | 2011 |
The impact of statin and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker therapy on cognitive function in adults with human immunodeficiency virus infection KM Erlandson, D Kitch, CW Wester, RC Kalayjian, ET Overton, ... Clinical Infectious Diseases 65 (12), 2042-2049, 2017 | 19 | 2017 |
The impact of statin and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker therapy on cognitive function in adults with human immunodeficiency virus infection KM Erlandson, D Kitch, CW Wester, RC Kalayjian, ET Overton, ... Clinical Infectious Diseases 65 (12), 2042-2049, 2017 | 19 | 2017 |